Aktiespararna Direktavkastning A vs BGF World Healthscience

Aktiespararna Direktavkastning A vs BGF World Healthscience

1. Aktiespararna Direktavkastning A

  • Security

    Aktiespararna Direktavkastning A

  • Fee

    0.30%

  • ISIN

    SE0008321780

  • Holdings

    26

2. BGF World Healthscience

  • Security

    BGF World Healthscience A2

  • Fee

    2.17%

  • ISIN

    LU0122379950

  • Holdings

    10

Fund Holdings

We have information about 36 holdings in Aktiespararna Direktavkastning A, where the largest holding is Axfood (5.69), followed by Tele2 (5.43) and Avanza (5.17). In comparison with BGF World Healthscience, we have 20 holdings where UnitedHealth is the largest holding (8.2), followed by Eli Lilly (7.01) and Novo Nordisk (6.67).

All Holdings

Here we compare the holdings in Aktiespararna Direktavkastning A and BGF World Healthscience.

Aktiespararna Direktavkastning A BGF World Healthscience
1. Axfood AB
Sweden
5.69 %
1. UnitedHealth Group Inc
USA
8.2 %
2. Tele2 B
Sweden
5.43 %
2. Eli Lilly and Co
USA
7.01 %
3. Avanza Bank Holding
Sweden
5.17 %
3. Novo Nordisk B
Denmark
6.67 %
4. Telia Company AB
Sweden
5.05 %
4. Merck & Co Inc
Germany
3.99 %
5. Swedbank A
Sweden
4.93 %
5. Boston Scientific Corp
3.67 %
6. Autoliv SDB
Sweden
4.91 %
6. AbbVie Inc
USA
3.61 %
7. Nordea Bank Abp
Finland
4.83 %
7. Amgen Inc
3.58 %
8. Stora Enso R
Finland
4.8 %
8. Sanofi SA
France
3.05 %
9. Hennes & Mauritz B
Sweden
4.72 %
9. Abbott Laboratories
USA
3.02 %
10. Handelsbanken A
Sweden
4.65 %
10. AstraZeneca
Sweden UK
2.98 %
11. Ericsson B
Sweden
4.57 %
-
12. SKF B
Sweden
4.57 %
-
13. Holmen B
Sweden
4.55 %
-
14. SEB A
Sweden
4.53 %
-
15. Securitas B
Sweden
4.48 %
-
16. Skanska B
Sweden
4.45 %
-
17. Husqvarna B
Sweden
4.44 %
-
18. Essity B
Sweden
4.38 %
-
19. SSAB B
Sweden
4.27 %
-
20. Billerud AB
Sweden
4.22 %
-
21. Elekta B
Sweden
4.16 %
-
22. Volvo B
Sweden
3.98 %
-
23. JM
3.65 %
-
24. Boliden AB
Sweden
3.43 %
-
25. Intrum AB
2.14 %
-
26. SBB B
1.2 %
-

The list of fund holdings was last updated on June 5, 2025.